Skip to main content
Biocon shares gain 2% on USFDA nod for insulin glargine injection - Moneycontrol.com 13-Jun-2020
Biocon shares gain 2% on USFDA nod for insulin glargine injection - Moneycontrol.com
Biocon and Mylan N.V. announced that the US Food and Drug Administration has approved the New Drug Application for Semglee (insulin glargine injection) in vial and pre-filled pen presentations
More...